Semaglutide
GLP-1 Receptor AgonistA GLP-1 receptor agonist that reduces appetite, increases feelings of fullness, and slows gastric emptying — resulting in decreased calorie intake while modulating insulin and glucagon levels.
Wegovy shares this Semaglutide foundation and is specifically indicated for chronic weight management — harnessing GLP-1 to promote sustained, measurable weight loss.